AzTrials
AzTrials

Female Urinary IncontinenceNCT06291441

Women Urinary Incontinence Prevalence Study (WUIPS)

An observational study of Female Urinary Incontinence, run by IRCCS San Raffaele at 4 sites in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this multicenter prospective and prevalence observational study is to punctually investigate and describe prevalence, predictors, quality of life and costs of Urinary Incontinence (UI) among female patients, female caregivers and female personnel in four hospitals in Northern Italy: San Raffaele hospital… Read more about this study

Who is it for?
Ages 40 to 65 years, women onlyHealthy volunteers can take part
Conditions the study is for
Female Urinary Incontinence
How many people
449 participants
Where
4 sitesItaly
Study dates
3 Jul 2024to 31 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 65 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All female patients, female caregivers, female healthcare professionals and female administrative workers who meet the inclusion criteria will be included. Participants will be enrolled in four centers in Northern Italy which are the reference centers for UniSR: San Raffaele hospital in Milan, San Raffaele Turro hospital in Milan, Zingonia Policlinico San Marco (BG) and Policlinico San Pietro in Ponte San Pietro (BG).

Who may be able to join

  • Female sex
  • Middle age (40-65 years old)
  • Informed consent signed
  • Comprehension of written and spoken Italian language
  • Female outpatients intended for any hospital unit (outpatient clinic, day surgery and day hospital patients included) and every female caregiver respecting the previous inclusion criteria, recruited at the central admission and at the private admission of the four hospitals involved
  • Female workers (healthcare professionals and administrative personnel) of the four hospitals

Who cannot join

  • Male sex
  • Young age (< 40 years) and older age (> 65 years)
  • Pregnant women
  • Puerperium women (up to 40 days post-partum)
  • Women who had undergone urinary and gynecology surgery

Trial locations and contacts

4 sites in 1 country.

Sara Trapani contact

338 9879403

trapani.sara@hsr.it

Giulia Villa contact

0291751779

villa.giulia@hsr.it

Italy4 sites, 4 recruiting
  • Policlinico San Pietro Ponte San Pietro

    Bergamo, 24036

    Elisabetta Bagnato, elisabetta.bagnato@grupposandonato.it

    Giulia Villa, 0291751779, villa.giulia@hsr.it

    Recruiting
  • San Raffaele Turro Hospital (MI)

    Milan, 20127

    Sara Trapani, +39 3389879403, trapani.sara@hsr.it

    Giulia Villa, 0291751779, villa.giulia@hsr.it

    Recruiting
  • San Raffaele Hospital (MI)

    Milan, 20132

    Sara Trapani, +39 3389879403, trapani.sara@hsr.it

    Giulia Villa, 0291751779, villa.giulia@hsr.it

    Recruiting
  • Policlinico San Marco Zingonia

    Osio Sotto, Bergamo, 24040

    Elisabetta Bagnato, elisabetta.bagnato@grupposandonato.it

    Giulia Villa, 0291751779, villa.giulia@hsr.it

    Recruiting

Other trials in Italy

About this study

Official title: Female Urinary Incontinence in Middle-aged Women in Four Hospitals in Northern Italy: a Multicenter Prevalence Study

The goal of this multicenter prospective and prevalence observational study is to punctually investigate and describe prevalence, predictors, quality of life and costs of Urinary Incontinence (UI) among female patients, female caregivers and female personnel in four hospitals in Northern Italy: San Raffaele hospital in Milan, San Raffaele Turro hospital in Milan, Zingonia Policlinico San Marco (BG) and Policlinico San Pietro in Ponte San Pietro (BG).

Read the detailed description

EXPECTED RESULTS

The collection of data and information through this study will aim to:

  1. Understand the percentage of middle-aged women with UI.
  2. Describe the socio-demographic and clinical characteristics of women with UI.
  3. Identify UI predictors.
  4. Describe the quality of life, social impact and costs of women with UI.
Being tested
No intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

    No intervention (observational study)

Study groups in NCT06291441
Study groupRoleWhat they receive
Women's single sampleINSTRUMENTS: * UI Survey: A survey, written in Italian by the authors, will collect women's socio-demographic, economic and clinical characteristics * Italian version of International Consultation of Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ UI-SF) * Italian version of Incontinence Impact Questionnaire-7 (IIQ-7)
Receives: Other: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of middle-aged women with urinary incontinence

    Epidemiological data

    Measure:

    • Italian version of International Consultation of Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ UI-SF)

    Measured: by December 2025

Secondary outcomes (4)
  1. Predictors of urinary incontinence in middle-aged women

    Description and association between UI and related predictors

    Measure:

    • UI Survey: A part of the survey, written in Italian by the authors, will collect women's socio-demographic and clinical characteristics (predictors of UI)

    Measured: by December 2025

  2. Quality of life of middle-aged women with urinary incontinence

    Description and association between UI and quality of life

    Measure:

    • Italian version of Incontinence Impact Questionnaire-7 (IIQ-7) for investigating women's quality of life

    Measured: by December 2025

  3. Social impact of middle-aged women with urinary incontinence

    Description and association between UI and social impact

    Measure:

    • UI Survey: A part of the survey, written in Italian by the authors, will collect social impact of UI through a 4-point Likert scale

    Measured: by December 2025

  4. Costs of urinary incontinence for middle-aged women

    Description of UI costs

    Measure:

    • UI Survey: A part of the survey, written in Italian by the authors, will collect costs of UI through a 5-point Likert scale

    Measured: by December 2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2024
  2. Study start3 Jul 2024
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
449 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06291441
Sponsor's protocol ID
WUIPS
Status last verified
Sep 2024
First submitted
16 Feb 2024
Last updated
19 Sep 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Female Urinary Incontinence, run by IRCCS San Raffaele at 4 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sara Trapani (338 9879403, trapani.sara@hsr.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of middle-aged women with urinary incontinence (time frame: by December 2025). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in